This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Elghetany MT . True histiocytic lymphoma: is it an entity? Leukemia 1997; 11: 762–764.
Pileri SA, Grogan TM, Harris NL, Banks P, Campo E, Chan JK et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 2002; 41: 1–29.
Ralfkiaer E, Delsol G, O'Connor NT, Brandtzaeg P, Brousset P, Vejlsgaard GL et al. Malignant lymphomas of true histiocytic origin. A clinical, histological, immunophenotypic and genotypic study. J Pathol 1990; 160: 9–17.
Soslow RA, Davis RE, Warnke RA, Cleary ML, Kamel OW . True histiocytic lymphoma following therapy for lymphoblastic neoplasms. Blood 1996; 87: 5207–5212.
Rajkumar SV, Dispenzieri A, Fonseca R, Lacy MQ, Geyer S, Lust JA et al. Thalidomide for previously untreated indolent or smoldering multiple myeloma. Leukemia 2001; 15: 1274–1276.
Bessmertny O, Pham T . Thalidomide use in pediatric patients. Ann Pharmacother 2002; 36: 521–525.
Baidas S, Tfayli A, Bhargava P . Thalidomide: an old drug with new clinical applications. Cancer Invest 2002; 20: 835–848.
Gupta D, Treon SP, Shima Y, Hideshima T, Podar K, Tai YT et al. Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications. Leukemia 2001; 15: 1950–1961.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dalle, J., Leblond, P., Decouvelaere, A. et al. Efficacy of thalidomide in a child with histiocytic sarcoma following allogeneic bone marrow tranplantation for T-ALL. Leukemia 17, 2056–2057 (2003). https://doi.org/10.1038/sj.leu.2403075
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403075
This article is cited by
-
Histiocytic sarcoma and underlying chronic myelomonocytic leukemia: a proposal for the developmental classification of histiocytic sarcoma
International Journal of Hematology (2010)